Cascade Investment Group, Inc. Merck & Co., Inc. Transaction History

Cascade Investment Group, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 16, 2024	BUY	$100.18 - $109.02 $8,314 - $9,048	83 Added 2.8%	3,050 $333 Million
Q3 2023 Oct 18, 2023	BUY	$102.95 - $114.33 $1,544 - $1,714	15 Added 0.51%	2,967 $305 Million
Q2 2023 Jul 19, 2023	BUY	$108.61 - $118.38 $2,063 - $2,249	19 Added 0.65%	2,952 $341 Million
Q1 2023 Apr 14, 2023	SELL	$102.94 - $114.86 $82,969 - $92,577	-806 Reduced 21.56%	2,933 $312 Million
Q4 2022 Feb 27, 2023	BUY	$87.44 - $112.11 $326,938 - $419,179	3,739 New	3,739 $415 Million

3,830

1.91B

13.4M

10.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $288B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Cascade Investment Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Cascade Investment Group, Inc. with notifications on news.